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Abstract
Comparative genomic analyses of Leishmania species have revealed relatively minor het-
erogeneity amongst recognised housekeeping genes and yet the species cause distinct
infections and pathogenesis in their mammalian hosts. To gain greater information on the
biochemical variation between species, and insights into possible metabolic mechanisms
underpinning visceral and cutaneous leishmaniasis, we have undertaken in this study a
comparative analysis of the metabolomes of promastigotes of L. donovani, L.major and L.
mexicana. The analysis revealed 64 metabolites with confirmed identity differing 3-fold or
more between the cell extracts of species, with 161 putatively identified metabolites differing
similarly. Analysis of the media from cultures revealed an at least 3-fold difference in use or
excretion of 43 metabolites of confirmed identity and 87 putatively identified metabolites
that differed to a similar extent. Strikingly large differences were detected in their extent of
amino acid use and metabolism, especially for tryptophan, aspartate, arginine and proline.
Major pathways of tryptophan and arginine catabolism were shown to be to indole-3-lactate
and arginic acid, respectively, which were excreted. The data presented provide clear evi-
dence on the value of global metabolomic analyses in detecting species-specific metabolic
features, thus application of this technology should be a major contributor to gaining greater
understanding of how pathogens are adapted to infecting their hosts.
Introduction
Leishmaniasis is a debilitating disease for approximately 12 million people living mainly within
the tropics [1], caused by some 20 species of the protozoan parasite Leishmania [2]. Leish-
mania has a digenetic life cycle alternating between motile, extracellular promastigotes in the
insect vector and non-motile, intracellular amastigotes in the mammalian host. The parasite
replicates as procyclic promastigotes in the gut of phlebotomine sandflies, differentiating to
non-replicating but infectious metacyclic promastigotes that are injected into the mammalian
bloodstream when the insect feeds. The metacyclic promastigotes are taken up by mononuclear
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phagocytes where they differentiate into and replicate as amastigotes within a parasitophorous
vacuole. The disease pathology is dependent upon the species of the infecting Leishmania with
the so-called cutaneous, mucocutaneous and visceral leishmaniases resulting from intracellular
infection with the amastigote form of the parasite of primarily macrophages in, respectively,
superficial subcutaneous tissue, submucosal tissues of the nose and mouth, or internal organs
including, in particular, the liver and spleen. The diseases caused are of differing severity, with
visceral leishmaniasis being lethal if not treated. The pathogenicity of Leishmania is known to
be mainly determined by the parasite species itself, although the aetiology underlying the dif-
ferent clinical outcomes is not fully understood and it is clear that the immune status of the
host and co-infections with other pathogens such as HIV and tuberculosis can affect pathoge-
nicity [2].
The major causative agent of visceral leishmaniasis is L. donovani, whilst two major agents
responsible for cutaneous leishmaniasis are L.major and L.mexicana. It was anticipated that
the differing abilities of various Leishmania species to survive in different host tissues and the
resultant differing pathogenicity would be explained by species-specific genes. However, com-
parative analyses of the genomes of L.major, L. braziliensis and L. infantum [3] and L. dono-
vani and L.mexicana [4,5,6] have revealed not only a strong conservation of gene content and
synteny, but also rather few species-specific genes. Moreover, these species-specific genes have
not so far provided the information necessary to decipher the different disease phenotypes [4].
Thus the phenotypic differences between the various species are now thought to be due to a dif-
ferential regulation of gene expression and protein functions and not simply due to the posses-
sion of different genes. This suggests that a detailed analysis of transcriptomic and proteomic
variations may help identify the mechanisms that underpin disease tropism, but also that anal-
ysis of the metabolomes, the net end products of gene transcription, of each parasite should
provide key information on the web of complex metabolite interactions that are responsible for
disease tropism and give some indication of genes which are differentially regulated in the dif-
ferent species.
Methods and technologies for the detection, identification and measurement with high
specificity of the metabolites within a cell and its environment have improved immensely in
recent years and have spawned the burgeoning field of ‘metabolomics’. They are now available
to be applied in research on pathogens such as parasites and so contribute significantly to
understanding their biology as well as enabling better drug discovery, disease diagnostics and
treatment [7,8]. Several studies on the metabolomes of Leishmania have been reported to date,
yielding both detailed methods that can be successful and insights into the biochemistry and
mechanisms of drug resistance of individual species [9–14]. All have involved analysis of the
promastigote forms of a single parasite species with only one study analysing the amastigote
form at all; this reflects the lack of methods for obtaining amastigotes pure and in sufficient
numbers for analysis of this type.
Logarithmic and stationary phase promastigotes from in vitro cultures showed distinct
metabolic profiles, thought to reflect increased differentiation into metacyclic forms
[10,11,13]. Differences included decreased levels of nucleosides, increased levels of nucleo-
bases and apparent changes in membrane glycerol phospholopid structure predicted to lead
to lower membrane fluidity. Logarithmic and stationary phase promastigotes have also been
compared with amastigotes, albeit those obtained from in vitro cultures and known as axenic
amastigotes, using L. mexicana. [13]. This study showed that promastigotes in culture con-
sume more glucose and some amino acids than they need, releasing partially catabolised
products into the medium. Analysis with C13-U-glucose revealed the release of C13-labeled
CO2, succinate, alanine, acetyl-CoA and to a lesser extent aspartate, malate, glutamate and
glutamine. Similarly, label from C13-U-glutamate was incorporated into the secreted
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metabolites CO2, succinate, alanine, acetyl-CoA and glutamine, with highest levels released
by logarithmic phase promastigotes. In contrast, these metabolites were hardly secreted by
axenic amastigotes. Indeed, the amastigotes were shown to have a slower metabolism and
used glucose and amino acids sparingly, even when present at high concentration in the
medium. This was referred to as the stringent metabolic response and is characterised by a
decrease in uptake and catabolism of glucose and amino acids and an increase in fatty acid
catabolism by β-oxidation. These authors also reported that amastigotes derived from lesions
in animals have a similar metabolic profile to axenic amastigotes, thus indicating that the dif-
ferences between axenic amastigotes and promastigotes should also reflect naturally-occur-
ring differences. Metabolomic profiling of promastigotes has also been used to investigate
the mode of action of antileishmanial drugs [9,11,12,14]; unfortunately it is not currently
possible to investigate amastigotes, the disease causing stage, in the same way. Comparison
of L. donovani strains with different susceptibility to sodium stibogluconate identified
numerous metabolic differences including levels of intermediates in pathways linked to pro-
tection against oxidative stress (arginine metabolism for production of spermidine, transsul-
furation pathway producing cysteine) and composition of glycerol phospholipids, resulting
in higher membrane fluidity [9,11]. In contrast, metabolomic and lipidomic analysis of L.
infantum promastigotes [12] showed that membrane phospholipids were not altered follow-
ing treatment with miltefosine, although an increase in the turnover of internal membrane
lipids was indicated by increases in alkane fragments.
These few previous metabolomic studies have involved different Leishmania species and
varying approaches which make species comparison difficult. Thus the main aim of this cur-
rent study was to use an untargeted metabolomics approach to gain information on the dif-
ferences in the metabolic profiles of the three different species, with the hope that this may
provide interesting insights into the innate biological variations and possibly enable hypothe-
ses to be formulated concerning the adaptations of the individual species to their distinct
niches within the mammalian host. We studied the lines of L. donovani, L.major and L. mex-
icana used for the benchmark genome analyses [3–5] and further developed our mass spec-
trometry-based metabolomics techniques to include confirmation of the identity of many of
the metabolites by comparison with standards or by interpretation of MS2 spectra of signifi-
cantly varying metabolites for which there were no standards. In addition, quantification of
the levels of significant metabolites in the spent growth media was carried out. The enhanced
methodologies developed have been used to compare the metabolomes of promastigotes at
equivalent stages of in vitro growth and the changes in the media resulting from parasite
growth.
Materials and Methods
Leishmania parasites
L. donovani (MHOM/NP/03/BPK282/0 clone 14), L.major (MHOM/IL/81/Friedlin) and L.
mexicana (MHOM/GT/2001/U1103, clone 25) were used in this study. L. donovani promasti-
gotes had been cloned from an isolate from a visceral leishmaniasis patient sensitive to penta-
valent antimonials in Nepal, as descrifbed by Rijal and co-workers [15]. L. donovani, L.major
and L.mexicana promastigotes were grown in modified Eagle’s medium (designated HOMEM
medium, Invitrogen) supplemented with 10% (v/v) heat inactivated fetal calf serum (FCS, PAA
Laboratories) and at 26°C. The same batch of serum was used for all cultures. Cultures were set
up initially at a concentration of 2.5 x 105 parasites/ml and all parasites were harvested for
metabolite extraction after 3 or 6 days of in vitro growth; the growth progression of the cultures
was monitored quantitatively by microscopic analysis.
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Chemicals and solvents
High performance liquid chromatography (HPLC) grade acetonitrile (ACN), chloroform and
methanol were purchased from Fisher Scientific, UK. HPLC grade water was produced by a
Direct-Q 3 Ultrapure Water System fromMillipore, UK. AnalaR grade formic acid (98%) was
obtained from BDH-Merck, UK. Ammonium carbonate, ammonium hydroxide solution (30–
33%), all the standard compounds and the reagents and kits required for the various assays per-
formed were purchased from Sigma-Aldrich, UK.
Preparation of mixed metabolite standard solutions
Each metabolite standard was prepared at 1 mg/ml with HPLC grade methanol and water (1:1,
v/v) and stored at -20°C. 100 μl was taken from each stock solution and about 45 metabolites
were mixed and then made up to 10 ml with acetonitrile for each standard solution (see S1
Table for details of compositions). Consequently, the final concentration for each metabolite
standard was 10 μg/ml with 185 metabolite standards being distributed into the four mixed
metabolite standard solutions (detailed in S1 Table). In order to avoid identity confusion, iso-
mers were distributed into different standard solutions and the presence of in-source fragments
producing spurious metabolites was also carefully verified. These standards were run routinely
to aid identification of sample metabolites. The names and formulae of these 185 metabolite
standards are given in S1 Table. Additional metabolite standards were also used in this study
for identification of the LC-MS (liquid chromatography mass spectrometry) features that
showed clear species-specificity; they were prepared as described above and are detailed in S2
Table.
Leishmania extracts for metabolite analysis
Promastigotes from four independently growing 10 ml cultures (biological replicates) were
harvested after 6 days at 26°C and metabolite extraction was performed as previously described
[16]. Briefly, the 10 ml cultures containing promastigotes were quenched in a dry ice/ethanol
bath by rapid temperature decrease to 2°C and immediately transferred to ice. The samples
were maintained at low temperature throughout the extraction procedure to prevent the inter-
conversion of metabolic intermediates. Two aliquots of 4 x 107 cells were taken from each cul-
ture flask (one for metabolite extraction and the other for protein estimation) and harvested by
centrifugation at 1800 x g for 10 min at 4°C, the supernatant (designated the spent medium)
was removed and stored on ice. Cell pellets were washed 2 times in 1 ml of phosphate buffered
saline (PBS) at 4°C by centrifugation at 1800 x g for 10 min at 4°C. For cell disruption and
metabolite extraction, cell pellets were resuspended in 200 μl cold chloroform/methanol/water
(20/60/20, v/v/v) and incubated 1 h in a Thermomixer (14,000 rpm, 4°C). Proteins precipitated
by the organic solvent in the extraction buffer were removed by centrifugation at 12,000 g for
10 min at 4°C. The supernatant containing the extracted metabolites was then recovered and
stored at -70°C until analysed. To 75 μl of spent medium was added 300 μl of cold chloroform/
methanol (20/60, v/v) followed by incubation for 1 h in a Thermomixer (14,000 rpm, 4°C).
After centrifugation at 12,000 g for 10 min at 4°C, the supernatant was recovered and stored at
-70°C until analysed.
Metabolic profiling by LC-MS
The metabolic profiling was performed on an Accela 600 HPLC system combined with an
Exactive (Orbitrap) mass spectrometer from Thermo Fisher Scientific (Bremen, Germany).
The LC conditions used for ZIC-HILIC (Hydrophilic Interaction Liquid Chromatography)
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were the same as in our previous studies [16] and for ZIC-pHILIC were as follows. 10 μl of
samples was injected onto a ZIC-pHILIC column (150 mm×4.6 mm; 3.5 μm, Merck, Germany)
with mobile phase A being 20 mM ammonium carbonate in HPLC grade water (pH 9.2) and
mobile phase B being HPLC grade acetonitrile. The eluting gradient was initiated with 80% of
B and decreased to 20% B over 30 min. B was further decreased to 8% at 31 min and held at
this to 36 min for washing the column. B was then increased to 80% from 37 min and held at
this to 46 min for re-equilibration of the column. The flow rate was 0.3 ml/min for the whole
eluting gradient. The LC-MS run involved initially two solvent blanks for equilibrating the col-
umn, then the four standard metabolite solutions, and then the experimental samples ran-
domly sequenced. The mass spectrometer settings were as follows. The Electospray Ionisation
(ESI) interface was operated in a positive/negative polarity switching mode. The spray voltage
was 4.5 kV for positive mode and 4.0 kV for negative mode. The temperature of the ion transfer
capillary was 275°C and sheath and auxiliary gas flow was 50 and 17 arbitrary units, respec-
tively. The full scan range was 75 to 1200 m/z for both positive and negative modes with set-
tings of AGC target and resolution as Balanced and High (1e6 and 50,000), respectively. The
data were recorded using the Xcalibur 2.1.0 software package (Thermo Fisher Scientific). Mass
calibration was performed for both ESI polarities before the analysis using the standard
Thermo Calmix solution with addition of some additional compounds to cover the low mass
range and the signals of 83.0604 m/z (2xACN+H) and 91.0037 m/z (2 x formate-H) were
selected as lock masses for positive and negative mode, respectively, during each analytical run.
Data processing
The LC-MS raw data of the metabolite standard solutions were processed using ToxID 2.1
(Thermo Fisher Scientific Inc., Hemel Hempstead, UK) with ± 3 ppm (parts per million) mass
accuracy tolerance with both ESI positive and negative modes. The generated extracted ion
chromatograms of metabolite standards on different columns were visually evaluated with
respect to peak shapes and their retention times are detailed in S1 Table.
The data processing for biological samples initially involved centroiding and converting
vendor-specific raw LC-MS files into the mzXML open format. Chromatographic peaks in
these files were extracted using the detection algorithm from XCMS [17] and stored in corre-
sponding PeakML files [18]. Subsequently, PeakML files representing replicates were aligned
and combined using mzMatch.R [19] after filtering out all peaks that were not reproducibly
detected. The combined PeakML files were subjected to additional noise filtering and gap-fill-
ing for peak quality control. Finally the generated CSV files were imported into IDEOM for
metabolite putative identification based on accurate mass (±3 ppm) and retention time predic-
tion [20]. The lipids and peptides were excluded from the lists of putatively identified metabo-
lites in the biological samples.
Metabolite identification
In order to confirm identity of metabolites to the metabolic standards initiative (MSI) level 1
[21], the two orthogonal methods of retention time matching (to ± 0.2 min) against a standard
and accurate mass to< 3 ppm were used. Metabolites indentified to level 2 were identified by
accurate mass to< 3 ppm and also by predicted retention time [22]. A subset of metabolites
identified to level 2 which proved to be biologically interesting to this study but for which no
authentic standards were available were identified to level 1 by obtaining interpretable MS2
spectra. MS2 was carried out by using a Surveyor HPLC system combined with a LTQ-Orbitrap
mass spectrometer from Thermo Fisher Scientific (Bremen, Germany) by using Collision
Induced Dissociation (CID) at 35 V with the activation Q 0.25 and activation time 30 ms. The
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same LC gradient programs described above were used and the selective MS2 fragments were
accurate to ± 5 ppm. The obtained MS2 data were compared with the standard spectra in the
METLIN database or interpreted if there were no published standard spectra available.
Normalisation of metabolite levels
The levels of the metabolites in the biological samples are expressed as intensity/2 x 106 pro-
mastigotes (parasite extracts) or intensity/2 μl medium (media samples). To ensure validity of
comparisons between samples, the protein content of the parasite pellets collected were deter-
mined according to the Bradford procedure (BioRAD), using bovine serum albumin as the
protein standard.
Statistical analysis
Principal Component Analysis (PCA) was carried out by using SIMCA-P 13 (Umetrics, Swe-
den). Prior to PCA, the data were mean-centered and unit variance (UV) scaled. The Student’s
T test was performed for all individual putatively identified metabolites: a p value smaller than
0.05 (p<0.05) was considered significant; GraphPad Prism 4 was used for plotting the graphs.
Quantification of confirmed metabolites of interest
In order to determine the concentrations of amino acids in the spent media, a mixture of
amino acids (Sigma Aldrich, Product No. A9906) was diluted with the cell extraction buffer
chloroform/methanol/water (20/60/20, v/v/v) to give final concentrations at 50, 5, 0.5, 0.05 and
0.005 μmol/L for each compound. For other metabolites of interest (including phenyl pyruvate,
phenyl lactate, 4-hydroxyphenyl pyruvate, 4-methyl-2-oxopentanoic acid, 3-methyl-2-oxopen-
tanoic acid, hydroxyisovaleric acid and 3-(4-hydroxyphenyl) lactate), calibration series were
prepared with concentrations at 10000, 1000, 100, 10, 1 ng/ml in chloroform/methanol/water
(20/60/20, v/v/v). To take into account medium matrix effects, the calibration series for trypto-
phan was prepared with L.major spent medium (which lacked detectable tryptophan) and
indole-3-pyruvate, indole-3-lactate and indole-3-acetate with complete medium; 75 μl of the
diluted samples were then extracted with 300 μl of the medium extraction buffer—chloroform/
methanol (20/60, v/v). Due to the poor chromatographic performace in HILIC mode, some of
the metabolites (phenyl lactate, 4-methyl-2-oxopentanoic acid, 3-methyl-2-oxopentanoic acid,
hydroxyisovaleric acid and 3-(4-hydroxyphenyl) lactate) were quantified using a reversed
phase LC method which was developed in our previous study [23], although the initial observa-
tion of differences was based on the data from chromatography on ZICpHILIC.
Analysis of enzymes involved in tryptophan metabolism
Promastigotes from day 3 and day 6 cultures were harvested, washed in ice-cold PBS, and
resuspended in lysis buffer (25 mM sucrose, 0.25% Triton X-100, 10 μM E-64, 1 mM phenan-
throline, 20 mM pepstatin A, 0.2 M PMSF) at 5 x 108/ml (day 3 cultures) and 109/ ml (day 6
cultures). They were lysed by aspirating 4 times with a Gilson pipette and the extracts were
cleared by centrifugation at 14,000 x g for 20 minutes at 4°C and stored at -80°C. The protein
concentration was determined using the Bradford assay (Bio-Rad).
Tryptophan aminotransferase activity was determined by the method of Szkop et al. [24].
0.5 ml of 200 mM Tris HCl, pH 7.5, containing 10 mM tryptophan, 5 mM oxaloacetate and
0.04 mM pyridoxal-5-phosphate was incubated for 3 min before adding 50 μl of promastigote
extract. 100 μl samples were taken after a 2, 5, 10 and 20 min incubation and mixed with 200 μl
of Salkowski’s reagent (10 mM FeCl3 in 30% (v/v) H2SO4). 200μl aliquots were then transferred
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to a microtitre plate and incubated in the dark for 10–30 min at room temperature. The absor-
bance at 530 nm was measured in a SpectroMax plate reader and the indole-3-pyruvic acid
concentration was determined using a calibration curve that was linear for concentrations of
the authentic standard (Sigma) ranging from 2 to 100 μM. The reaction was dependent on
tryptophan, oxaloacetate and the promastigote extract.
Malate dehydrogenase (MDH) activity was determined in a 1 ml reaction containing 200
mM Tris HCl, pH 7.5, 5 mM oxaloacetic acid, and 200μMNADH. Reactions were started by
addition of 50 μl promastigote extract containing 20–60 μg protein and the rate of reaction
determined by monitoring the absorbance at 340 nm. The specific activity in nmol/min/mg
protein was calculated using the extinction coefficient for NADH of 6.22 mM-1 cm-1. Indole-
3-lactate dehydrogenase (Ind-LDH), phenyl-lactate dehydrogenase (Phe-LDH) and lactate
dehydrogenase (LDH) activities were determined by substituting 5 mM oxaloacetate with 1
mM indole-3-pyruvate, 1 mM phenyl pyruvate or 1 mM sodium pyruvate, respectively.
Indole-3-lactate dehydrogenase activity was also assayed in the forward reaction using 5 mM
indole-3-lactate and 0.2 mM NAD+. Reactions were carried out in 1 ml Tris HCl, pH 7.5, and
the rate was determined by monitoring absorbance at 340 nm.
Measurement of nitric oxide and ammonia in media samples
Media samples from day 6 cultures of the different Leishmania species (3 biological replicates)
were obtained by taking the supernatants after centrifugation of cultures at 1800 x g for 10 min
at 4°C, passing them through a 200μm filter and deproteinating them using a 3000 molecular
mass cut off spin column (Vivaspin 500). Nitric oxide (_NO) production was measured by
quantifying _NOmetabolites in 50 μl samples in a 200 μl reaction using a nitrate/nitrite assay
kit (Sigma) with a standard curve of 25–100 μM nitrite. Ammonia concentrations in 50 μl
medium samples were measured in 1 ml reactions using an ammonia assay kit (Sigma), with a
standard curve ranging from 0.2–15μg/ml ammonia.
Growth of Leishmania in medium containing different concentrations of
essential amino acids
HOMEMwithout amino acids was produced (by Invitrogen) according to the formula in Table A
in S3 Table. To prepare medium deficient only in ‘essential’ amino acids, L-glutamate (Invitrogen)
andMEM non-essential amino acids (Invitrogen) were added to this to provide the amino acid
composition shown in Table B in S3 Table. This modified HOMEM (designated mHOMEM)
lacked the 12 ‘essential’ amino acids Phe, Trp, Tyr, Leu, Iso, Val, His, Arg, Lys, Thr, Met and cys-
tine. Medium lacking just tryptophan or arginine were prepared by addition of appropriate amino
acid solutions to mHOMEM. Amino acids were removed from FCS by dialysis overnight two
times against a 10x volume of PBS at 4°C using a 3.5 kDa cut-off membrane, yielding dialysed FCS
(dFCS). Promastigotes from day 6 cultures in HOMEMwith 10% (v/v) FCS were washed twice by
centrifugation at 1800 x g for 10min at 4°C and resuspension to the initial volume in PBS. Cultures
were initiated with the washed promastigotes at 2.5 x 105 cells/ml in the various media. Growth
was monitored by determining cell densities at intervals using a haemocytometer.
Results
Comparison of the metabolomes of three Leishmania species and their
spent media
We have used a ZIC-HILIC column in an analysis of extracts from L. donovani previously [16],
whereas two HILIC methods of analysis (ZIC-HILIC and ZIC-pHILIC columns) were
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compared for their usefulness in the analysis of metabolites in L.major [25]. The aim was to
achieve the widest possible coverage of metabolites using a single column in order to maximise
efficiency of detection procedures and thus be able to apply them to a large number of samples.
Polar compounds and lipids were detected, however accurate identification of lipids could not
be achieved without extensive MS2 experiments because of the large number of isomers possi-
ble for a given molecular weight. We therefore decided to focus on polar compounds and lipids
were excluded from the analysis. This analysis showed clearly that for analysis of the metabolite
differences between Leishmania species involving a single chromatographic method, the ZIC-
pHILIC method is preferable to that with the ZIC-HILIC column, although this column
remains valuable for compounds such as polyamines. Thus ZIC-pHILIC method was chosen
for the general profiling of the Leishmania species extracts.
The metabolomes putatively identified by applying the ZIC-pHILIC analytical methodology
to extracts of promastigotes of three Leishmania species and their spent media were distinctly
different overall as shown by the PCA plots of the data (Fig 1). The data obtained are fully
detailed in S4 and S5 Tables; these include all putatively identified metabolites, identified by
accurate mass to< 3 ppm and by predicted retention time, as well as metabolites confirmed to
MSI level 1 by matching their retention times (± 0.2 min) against standard compounds or by
MS2 fragmentation in addition to accurate mass (the full list of confirmed metabolites is given
in S2 Table). Spectra of compounds characterised to level 1 by using MS2 were either compared
to spectra in the Metlin database or spectra were interpreted. S4 and S5 Tables detail the frag-
ments obtained by MS2 for metabolites of interest and S1 Fig shows the fragmentation pathway
for arginic acid as an example of MS2 spectrum interpretation. Using these approaches, we
confirmed the identity of 153 metabolites in the Leishmania extracts and 137 metabolites in
the spent media to MSI level 1, whereas there remained 459 and 548 metabolites identified
putatively in the respective samples on the basis of accurate mass and retention time predicted
by IDEOM (Table 1). The metabolites confirmed and putatively detected comprise a diverse
range of structures including purines, pyrimidines, amino acids and their metabolites, sugars,
sugar phosphates and intermediates in glycolysis and organic acids.
Fig 1. Principal Component Analysis of media and parasite samples. Principal Component Analysis (PCA) for cell extracts of three Leishmania species
(left, first two components explain 59.1% of the total variance) and for complete medium and spent media of three Leishmania species (right, first two
components explain 43.4% of the total variance). Key: blue, L. donovani; red, L.major; yellow, L.mexicana; green, complete medium. The confidence
ellipses are based on Hotelling’s T2 = 95% for both score scatter plots.
doi:10.1371/journal.pone.0136891.g001
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The most abundant intracellular and extracellular metabolites, based on relative MS
response, are shown as heatmaps that clearly indicate similarities and also differences between
the three species (S2 and S3 Figs) and the full list of metabolites, confirmed and putatively iden-
tified, which are significantly increased or depleted in the spent growth media compared with
the original complete medium are detailed in S5 Table.
As the main focus of this analysis was to discover differences between the metabolomes of
the three species that could provide insights into the biological characteristics of the species
themselves and the diseases that they cause, we concentrated on those metabolites for which
clear differences were found in intensity between equivalent samples from the three species. In
this study we have arbitrarily taken a 2-fold difference as the criterion for difference, although
we focused more on those metabolites showing a bigger variation. Of the metabolites con-
firmed in identity and putatively identified, 105 and 237, respectively, were different between
the extracts of at least two species, whereas 58 and 120, again respectively, differed in their
abundance in the spent media (see Table 1); the full datasets are presented as S4 (Leishmania
extracts) and S5 (spent media) Tables.
Our interpretative analysis has concentrated mainly upon those confirmed metabolites that
differed in abundance at least 3-fold between the extracts of different species and also those
that were consumed from the culture media or released into it in large amounts and there were
species differences of at least 3-fold in the consumption/release. These metabolites are listed in
Tables 2 and 3. The concentrations of some metabolites differed quite considerably between
species, and the trend of variation was not towards higher concentrations in any particular spe-
cies which gives reassurance that the data do not simply reflect differences in cell volume
between species. We addressed this issue by normalising the intensities against the protein con-
tent of the extracts, on the rationale that protein content is a good measure of cell volume (as
done previously [10]). Cell extracts of L. donovani, L.major and L.mexicana were found to
have similar protein contents of 124 ± 17, 99 ± 25 and 85 ± 5 μg per 4 x 107 cells, respectively,
indicating that their cell volumes differed by less than 35%. Thus assigning significance to
metabolites differing by more than 2-fold between species more than allows for any possible
influence of differences between cell volumes. Comparing intensity data normalised to cell pro-
tein content showed that all of those in Table 2 still differ by 2-fold and 87% still differ by
3-fold, thus confirming the robustness of the findings. Some metabolites that differ by<3-fold
based on cell volume probably differ by>3-fold if the data are normalised to cell protein, but
we have not added them to Table 2 to avoid undue complexity of the datasets. The metabolites
Table 1. Numbers of metabolites confirmed and putatively identified in cell extracts and spent media.
Cell extracts Spent media
Conﬁrmed(std, MS/MS) Putative Conﬁrmed(std, MS/MS) Putative
Metabolites after ﬁlteringlipids and peptides 153 (135, 18) 459 137 (119, 18) 548
2-fold difference frominitial medium na na 79 (63, 16) 173
No change from initialmedium na na 58 (56, 2) 375
No clear speciesspeciﬁcity 48 (43, 5) 222 21 (18, 3) 53
Clear species speciﬁcity (>2-fold change) 105 (92, 13) 237 58 (45, 13) 120
Clear species speciﬁcity(>3-fold change) 64 (55, 9) 161 43 (32, 11) 87
Clear species speciﬁcity(> 4-fold change) 52 (45, 7) 129 39 (30, 9) 68
Key: na, not applicable; std, using standards; the data on species speciﬁcity for the spent media are for the metabolites (79 conﬁrmed, 173 putative)
showing at least 2-fold differences from the initial medium.
doi:10.1371/journal.pone.0136891.t001
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Table 2. Metabolites of confirmed to MSI level 1 in promastigote extracts that differed by at least 3-fold in intensity between two species.
Metabolite Mass Ldon/Lmaj Ldon/Lmex Lmaj/Lmex
Glycine 75.0321 2.73 4.25 1.56
Serine 105.0426 1.69 4.44 2.63
Glycerate 106.0266 22.11 16.78 0.76
Imidazole-4-acetaldehyde 110.0480 4.93 2.11 0.43
Cytosine 111.0433 12.66 6.63 0.52
Proline 115.0634 0.22 0.12 0.57
Threonine 119.0583 8.49 2.13 0.25
Nicotinate 123.0320 0.79 0.11 0.14
Imidazole-4-acetate 126.0428 1.11 0.12 0.11
5-Oxoproline 129.0428 1.43 7.47 5.23
Pipecolate 129.0789 1.28 0.09 0.07
3-Methy2-oxopentanoic acid/4-Methy2-oxopentanoic acid 130.0631 0.59 2.90 4.90
trans-4-Hydroxy-proline 131.0582 2.63 3.32 1.26
Asparagine 132.0534 2.35 3.05 1.30
*Deoxyribose 134.0580 3.15 7.37 2.34
Homocysteine 135.0353 1.61 5.68 3.53
Hypoxanthine 136.0385 5.15 0.37 0.07
Ethanolamine phosphate 141.0192 1.87 0.23 0.12
2-Oxoglutarate 146.0216 1.95 5.97 3.07
O-Acetyserine 147.0532 2.28 3.17 1.39
*Ribose 150.0529 2.67 4.90 1.84
Xanthine 152.0335 16.91 0.21 0.01
*Xylitol 152.0686 4.76 3.73 0.78
Orotate 156.0172 0.29 0.12 0.43
Imidazole lactic acid 156.0535 4.72 2.06 0.44
proline carbamate 158.0690 9.18 2.62 0.29
N-acetyl valine 159.0894 18.61 39.95 2.15
N-gamma-Acetyldiaminobutyrate 160.0847 9.35 3.98 0.43
O-Acetyhomoserine 161.0689 16.70 1.52 0.09
Carnitine 161.1051 7.89 1.50 0.19
D3-phenyllactate 166.0631 3.42 8.28 2.42
3-(3-Hydroxy-phenyl)-propanoic acid 166.0632 4.14 11.59 2.80
N-Acetyleucine 173.1053 8.76 5.47 0.62
Citrulline 175.0957 5.18 2.45 0.47
*Sorbitol 182.0793 8.26 3.05 0.37
N-Acetylglutamine 188.0795 1.66 4.92 2.97
Gulonate 196.0585 2.41 30.95 12.83
Indole-3-lactate 205.0741 4.01 2.93 0.73
Deoxyuridine 228.0748 INF INF 0.00
Ribose 5-phosphate 230.0192 0.75 4.92 6.57
Cystine 240.0240 4.06 1.31 0.32
Uridine 244.0696 2.11 3.47 1.64
p-aminobenzoyl glutamate 266.0904 INF 15.50 0.00
N-(Arginino)succinate 290.1228 16.71 0.39 0.02
Glutathione 307.0841 3.62 1.03 0.28
Ribose 1,5-bisphosphate 309.9858 0.12 4.27 36.62
GMP 363.0586 4.15 1.93 0.47
Key: Ldon, intensity in L. donovani extract; Lmaj, intensity in L. major extract; Lmex, intensity in L. mexicana extract.
* Matches retention time of standard but ability of the method to separate all the isomeric possibilities not established.
doi:10.1371/journal.pone.0136891.t002
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that differ are from a diverse range of metabolic pathways and the data strongly support the
contention that different Leishmania species are quite distinct in their metabolism. The data
for metabolites in the spent media also are in agreement with this idea. They confirm the utili-
sation by the parasites of some purines and pyrimidines, but again show some species
Table 3. Metabolites confirmed to MSI level 1 in spent media samples that differed by at least 3-fold in intensity between two species.
Metabolite Mass Ldon/Lmaj Ldon/Lmex Lmaj/Lmex M/L.don M/L.maj M/L.mex
Glycerol 92.04724 17.31 1.88 0.11 0.22 3.75 0.41
Glycerate 106.0266 3.24 5.04 1.56 0.15 0.48 0.76
Cytosine 111.0433 10.08 5.81 0.58 0.71 7.14 4.12
Proline 115.0634 0.57 0.07 0.12 7.57 4.30 0.51
3-Methy2-oxobutanoic acid 116.0474 0.09 0.61 6.47 0.18 0.02 0.11
Succinate 118.0267 1.24 4.55 3.67 0.01 0.01 0.03
Nicotinate 123.032 2.73 0.07 0.03 0.58 1.59 0.04
*3-Methy2-oxopentanoic acid/4-Methy2-oxopentanoic acid 130.0631 0.83 6.69 8.09 0.02 0.02 0.16
Aspartate 133.0376 5.01 1.38 0.28 2.37 11.86 3.27
Deoxyribose 134.058 0.44 4.20 9.63 0.01 0.00 0.03
Hypoxanthine 136.0385 8.60 14.32 1.67 83.28 716.28 1192.67
4-Hydroxyphenylethanol 138.0681 0.03 0.53 16.57 0.78 0.03 0.42
Glutamate 147.0533 23.34 2.01 0.09 2.02 47.25 4.07
[FA oxo,methyl(4:0)] 2-oxo-4-methylthio-butanoic acid 148.0195 0.55 2.86 5.18 0.00 0.00 0.00
Xanthine 152.0335 34.08 1.00 0.03 20.02 682.19 20.03
N-acetyl valine 159.0894 3.18 2.03 0.64 0.16 0.51 0.33
Phenylpyruvate 164.0475 5.24 1.76 0.34 0.00 0.01 0.00
3-phenyllactate 166.0631 1.23 5.18 4.21 0.00 0.00 0.00
3-(3-Hydroxy-phenyl)-propanoic acid 166.0632 1.31 4.70 3.58 0.00 0.00 0.00
5-Guanidino-2-oxopentanoate 173.08 0.03 0.06 2.21 1.47 0.04 0.09
N-Acetylornithine 174.1004 5.62 1.50 0.27 1.74 9.81 2.61
Indole-3-acetate 175.0634 0.04 1.16 32.34 0.66 0.02 0.77
Arginic Acid 175.0957 0.11 0.24 2.22 0.00 0.00 0.00
Hippurate 179.0583 0.00 0.00 0.00 INF INF INF
3-(4-Hydroxyphenyl)pyruvate 180.0425 3.47 1.70 0.49 0.00 0.01 0.00
2-Phospho-glycerate 185.993 0.24 1.30 5.47 0.00 0.00 0.00
Tryptophan 204.0897 1016.88 1.40 0.00 1.99 2024.85 2.78
Cystathionine 222.0675 0.78 2.88 3.69 0.02 0.01 0.05
Deoxyuridine 228.0748 21.20 28.21 1.33 1.53 32.45 43.19
Cytidine 243.0854 5.95 12.44 2.09 1.47 8.74 18.28
Uridine 244.0696 INF INF 0.00 22.63 INF INF
Adenosine 267.0964 7.31 1.49 0.20 0.43 3.11 0.64
Guanosine 283.0917 0.00 0.00 0.00 INF INF INF
Sucrose 342.1162 0.00 0.00 0.00 INF INF 6.82
AMP 347.0635 0.00 0.00 0.00 INF INF INF
S-Adenosyhomocysteine 384.1214 0.28 2.02 7.28 0.00 0.00 0.00
Rafﬁnose 504.1696 3.33 0.76 0.23 1.66 5.51 1.27
Key: INF, metabolite absent from spent medium but present in original medium; M, intensity in complete medium; Ldon, intensity in L. donovani spent
medium; Lmaj, intensity in L. major spent medium; Lmex, intensity in L. mexicana spent medium; the ratios of the species is based on the ratio for each
with the complete medium.
*Combined acids co-eluting on ZIC-pHILIC. Separately quantiﬁed using C18 AR column.
doi:10.1371/journal.pone.0136891.t003
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specificity. Interestingly, the use of sucrose is much less by L.mexicana than the other two spe-
cies. The data also show large variations in metabolite release into the culture medium most
notably of succinate and deoxyribose. Glycerol and nicotinate are consumed by L.major but
apparently released into the growth medium by the other two species. The variation between
species is not consistent with simply a difference in growth rate or rate of differentiation to
metacyclic promastigotes as the selective consumption/release of particular metabolites dif-
fered between species. Moreover, the data on growth rates showed those of individual species
were relatively similar to each other indicating that the cultures were in the same growth phase
on day 6 when the extracts were prepared (S4 Fig). It is not possible to monitor the relative
rates of metacyclogenesis of the three species as there is no accepted method for distinguishing
the different forms of promastigotes that occur in cultures. However, to provide some informa-
tion on this we did compare the metabolomes in promastigotes that had been cultured for only
3 days and showed that the main differences detected between species in the day 6 analyses
detailed in this paper were also present in the day 3 samples (data not shown).
Many of the metabolites differing both intracellularly and extracellularly are amino acids or
derivatives of them. The identities of all amino acids in the biological samples were confirmed
to MSI level 1, which allowed for a full comparison of these compounds. The concentrations of
amino acids themselves in the unused medium are relatively high, thus supplying a rich source
for the parasites to consume. Comparing the observed intensities measured for each in the
original medium and the spent media after parasite growth showed that, for most, the amount
consumed was less than half of the original amount available (log2ratio<1 in Fig 2A, hence
many amino acids are not shown in the figure). However, for a few this was not the case and
also there was some clear species-specificity (Fig 2A). Notably, far greater percentages of the
aspartate, glutamate and tryptophan in the medium were used by L.major than by either of the
other two species, the tryptophan being totally consumed. In contrast, proline was apparently
used by L.major and L. donovani but released by L.mexicana, whereas each of arginine and
serine were more greatly consumed by L.mexicana than by the other species (Fig 2B). Some
amino acid derivatives were also released into the medium, including arginic acid, pipecolate,
phenylpyruvate, phenyllactate, 4-hydroxyphenyl pyruvate, 3-(4-hydroxyphenyl) lactate,
indole-3-pyruvate, indole-3-lactate and cystathionine (Fig 2 and Table 3). To gain a better
insight into the quantitative use of the amino acids, we generated standard curves for each
amino acid (S5 and S6 Figs) and used these to estimate the levels of each in the spent media
(Fig 2B and S6 Table). These data reiterated the species differences in the use of some amino
acids as described above, but also showed that in quantitative terms other amino acids were
also used and released in large amounts. L-alanine was released in quantity by all three species
and glycine was also released in quantity by L. donovani and L.major. Most other amino acids
were consumed, but the molar amounts used covered a wide range (for instance, 140 μM L-
threonine was consumed by L. donovani whereas only 5 μM L-valine was used by the same spe-
cies) and there were quite large differences between species although all species consumed
higher levels of serine, threonine and arginine than other amino acids. The clear differences in
utilisation of some amino acids by the three species was not reflected in the levels of the com-
pounds in the extracts from the cells (Fig 2C).
Uptake and catabolism of tryptophan
Tryptophan was shown to be totally consumed by L.major but less so by the other species,
thus we carried out a more detailed quantitative analysis of tryptophan and its catabolic prod-
ucts. We looked for likely products of tryptophan catabolism, both in the cell extracts and also
in the spent media, and confirmed the identity of metabolites found by comparison with
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Fig 2. Comparative consumption of amino acids frommedia and their intensities in parasite samples.
Ratios of amino acids and some derivatives in spent media in comparison with complete medium (A) and
between extracts of three Leishmania species (C). The ratios of amino acid intensity for complete medium
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authentic standards. We then quantified the amounts of the metabolites using standards to
produce calibration curves (S6 Fig). The data generated are presented in Table 4 and schemati-
cally in Fig 3. This analysis showed that little tryptophan was catabolised via the kynurenate
pathway in any of the three species and that most was transformed to indole-3-lactate and
released into the medium. Indole-3-lactate was not detected in the uninfected control media
samples confirming that it was synthesised in Leishmania and not the result of chemical
conversion.
Analysis of the tryptophan degradation pathway in L.major
We hypothesised that the extensive consumption of tryptophan and almost equimolar genera-
tion of indole-3-lactate by L.major was mediated by initial transamination of tryptophan to
indole-3-pyruvate followed by reduction of this to indole-3-lactate and that these were medi-
ated by the activities of an aminotransferase and hydroxyacid dehydrogenase, respectively (as
indicated in Fig 3). To test this, we assayed for tryptophan aminotransferase activity in protein
extracts from L. donovani, L.major and L.mexicana promastigotes after 3 and 6 days of in
vitro growth, using tryptophan (10 mM) and α-ketoglutarate, oxaloacetate, or pyruvate (each
at 5 mM) as co-substrates. The reaction was monitored by determining the generation of
indole-3-pyruvate [24]. L. donovani extracts at day 3 had the highest activity, with oxaloacetate
being the best co-substrate, with much lower activity being detectable in extracts of L.major
(Table 5). In contrast, assays using L.major extracts to test for indole-3-lactate dehydrogenase
activity in either the forward or reverse direction detected no activity (level of detection, 25
nmol/min/mg protein) and reactions with phenyl pyruvate (1 mM) or pyruvate (5 mM) and
NADH also showed no activity. However, incubation of rabbit muscle lactate dehyrogenase
(Roche) with pyruvate or phenyl pyruvate and NADH as a positive control produced a measur-
able rate (data not shown), although this enzyme also showed no activity with indole-3-pyru-
vate. As a second positive control, we confirmed that extracts of Leishmania had malate
dehydrogenase activity converting oxaloacetate to malate with NADH as the reducing agent
with specific activities of 49, 49 and 18 nmol/min/mg protein for L. donovani, L.major and L.
mexicana, respectively.
(Medium) to spent medium from each Leishmania are presented as log2. Only amino acids and their
derivatives which differ from the medium by > log21 for at least one species (2A) or between species
by > log21 (2C) are included. Key: black bar, Medium/L.mexicana; white bar, Medium/L. donovani; grey bar,
Medium/L.major. For extracts, intensity ratios between each pair of Leishmania species are expressed as
log2. Key: white bar, L.major/Lmexicana; black bars, L.major/L. donovani; grey bars, L.mexicani/L.donovani.
The amounts of amino acids consumed from the medium are also detailed for the three species (B).
doi:10.1371/journal.pone.0136891.g002
Table 4. Tryptophanmetabolites recovered in the spent media.
Complete medium L. donovani spent
medium
L. major spent medium L. mexicana spent
medium
mean ±SD mean ± SD % mean ±SD % mean ±SD %
Indole-3acetate 0.00 ±0.00 0.00 ±0.00 0.0 0.17 ± 0.01 0.9 0.00 ± 0.00 0.0
Indole-3-lactate 0.04 ±0.01 8.79 ±0.45 47.9 20.05 ± 1.68 109.3 12.75 ± 0.52 69.5
Indole-3-pyruvate 0.00 ±0.00 0.14 ±0.14 0.8 0.09 ± 0.04 0.5 0.07 ± 0.06 0.4
Kynurenate 0.01 ±0.00 0.04 ±0.01 0.2 0.06 ± 0.00 0.3 0.03 ± 0.01 0.2
Tryptophan 18.33 ±3.87 8.08 ±0.61 44.1 0.02 ± 0.00 0.1 5.70 ± 0.62 31.1
Key: %, % tryptophan in complete medium recovered in the spent medium as this metabolite; concentrations in μM.
doi:10.1371/journal.pone.0136891.t004
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Fig 3. Tryptophan catabolism in the three Leishmania species. Key: a, tryptophan aminotransferase or L-amino oxidase [48]; b, indole-3-lactate
dehydrogenese [48]; c, phenyl-pyruvate decarboxylase or indole-3-pyruvate decarboxylase (LmjF34.3250); d, indole-3-acetylaldehyde reductase; e, indole-
3-acetylaldehyde oxidase (LmjF26.2280); f, indole 2,3 deoxygenase or tryptophan 2,3 deoxygenase; g, acrylformamidase; h, kynurenine oxoglutarate
transaminase or cysteine-S-conjugate β-lyase or glutamine phenylpyruvate transaminase (LbrM33_V2.1600); i, kynurenine-3-monoxogenase; j, carboxy
lyase.
doi:10.1371/journal.pone.0136891.g003
Table 5. Tryptophan:oxaloacetate aminotransferase activities of Leishmania cell extracts.
Day 3 μmol/min/ mg protein Day 6 μmol/min/ mg protein
L. donovani 1.68 ± 0.48 0.49 ± 0.16
L. major 0.07 ± 0.04 0.22 ± 0.02
L. mexicana 0.21 ± 0.10 0.09 ± 0.01
Extracts were prepared from Leishmania cultures after 3 and 6 days growth at 26°C and assayed for
tryptophan aminotransferase activity with oxaloacetate as the co-substrate. Indole-3-pyruvate produced
was quantiﬁed using the method of Szkop et al. [24]. Activities represent the mean of 3 independent
reactions ± standard deviation.
doi:10.1371/journal.pone.0136891.t005
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Uptake and catabolism of arginine
Arginine was also used in large amounts and especially by L.mexicana, which reduced the
medium concentration by 175 μM; in contrast L. donovani only reduced the concentration by
45 μM (S6 Table and Fig 2B). To analyse the fate of this amino acid within the promastigotes,
we looked for the presence of potential catabolites both within the cell extracts and also the
spent media (Fig 4 and S7 Table). This revealed that a major route of catabolism was to arginic
acid, presumably mediated via the catalysis of an aminotransferase and dehydrogenase
enzymes in an analogous way to that in which tryptophan is degraded to indole-3-lactate (Fig
3). Interestingly, however, this route appears to have a greater flux in L.major than in L.mexi-
cana with more arginine being converted to argininosuccinate and polyamines in the latter
parasite.
Phenylalanine, tyrosine, leucine, isoleucine and valine deamination
Most amino acids in the spent medium were at>50% of their levels in the initial medium (S6
Table). Thus they were not limiting nutrients, but the differing amounts of the various amino
acids consumed (Fig 2C) suggested that some must be used in ways in addition to protein syn-
thesis. Analysis of putative metabolites potentially resulting from amino acid degradation sug-
gested that indeed there was significant amino acid degradation (S7 Fig). Further study to
confirm identities and quantify amounts showed there to be large amounts of the phenylala-
nine catabolites, phenylpyruvate and phenyllactate in the spent media from all three species,
the total levels of these two metabolites accounting for a significant proportion of the initial
concentration of phenylalanine in the complete growth medium and most of that consumed
(S8 Table). The levels of the tyrosine metabolites 4-hydroxyphenyl pyruvate and 3-(4-hydroxy-
phenyl)lactic acid in the spent media were also significant and the same was the case for the
acidic metabolites of leucine, isoleucine and valine; 4-methyl-2-oxopentanoic acid, 3-methyl-
2-oxopentanoic acid, alpha-hydroxyisovaleric acid, respectively (S8 Table). However, the
hydroxy-acid derivatives of the branched chain amino acids were not detected, presumably
reflecting the specificity or subcellular location of the hydroxy acid dehydrogenase. Glutamate
produced by aminotransferase activity with α-ketoglutarate as the amino acceptor is further
catabolised by glutamate dehydrogenase, releasing ammonia. We determined the ammonia
concentrations in the media. Complete medium contained 192 μM and the spent media con-
tained amounts in addition to this as follows: L. donovani, 24 μM; L.major, 49 μM; L.mexi-
cana, 85 μM.
Growth of Leishmania promastigotes with different concentrations of
amino acids
To determine the requirement of the different Leishmania species for an exogenous supply of
some amino acids, promastigotes were cultured in media with different amino acid concentra-
tions. Modified HOMEM (mHOMEM) was prepared without the ‘essential’ amino acids Trp,
Phe, Tyr, Leu, Iso, Val, Met, Lys, Arg, His, Thr and cystine (Table B in S3 Table) and washed
promastigotes inoculated into HOMEM and mHOMEM supplemented with FCS or dialysed
FCS (dFCS). FCS is a source of amino acids, peptides and protein; LC/MS analysis showed that
dialysis of the FCS with a cut-off of 3.5 kDa removed>95% of the selected amino acids (S8
Fig). Promastigotes of all three species grew equally well in HOMEM with 10% FCS and mHO-
MEM with 10% FCS even though the concentration of essential amino acids in the mHOMEM
medium, derived only from the FCS, was reduced 3 to 5-fold. Replacement of the FCS with
dFCS resulted in greatly reduced cell densities being reached and also reduced multiplication
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rates with all three species, irrespective of whether HOMEM or mHOMEM was used, although
the reduction in cell densities achieved was greater with dFCS in all cases. S9 Fig gives the
Fig 4. Arginine metabolism the three Leishmania species. The histograms give the relative levels of metabolites in cell extracts and supernatant media
(data are peak intensity (x 105) per 10 μl sample (equivalent to 2 x 105 cells) or 2 μl of medium). Data are presented in full detail in S7 Table. Key: a, arginase
(LmjF.35.1480); b, ornithine decarboxylase (LmjF.12.0280); c, spermidine synthase (LmjF.04.0580); d, nitric oxide synthase; e, argininosuccinate synthase
(LmjF.23.0260); f, arginine aminotransferase; g, hydroxyacid dehydrogenase. A soluble nitric oxide synthase has been reported for L. donovani [66] and
purified from L. braziliensis, L. chagasi [74] and L. amazonenzesis [74,75]. Genes for arginine aminotransferase and the hydroxyacid dehydrogenase have not
been found but these activities are assumed to be present.
doi:10.1371/journal.pone.0136891.g004
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detailed data for L.major. The cell density of L.major grown in HOMEM was reduced 2.8-fold
(P< 0.01) on day 3 and 10-fold (P< 0.001) on day 6 when 10% FCS was substituted with the
dialysed serum (media A and B in S9 Fig). Comparison of growth in HOMEM with 10% dFCS
(medium B) and mHOMEM with 10% dFCS (medium D) showed a 2.7-fold (P< 0.001)
reduction in titre. These results indicated that growth was limited by loss of growth factors
from the dialysed FCS in addition to a small effect from the loss of the essential amino acids. L.
major grown in media with dFCS remained viable as judged by microscopic observation and
re-grew when sub-cultured in medium containing FCS (HOMEM or mHOMEM) but not in
medium with dFBS.
The spent media samples from days 3 and 6 of the L.major cultures in HOMEM and mHO-
MEM with 10% FCS detailed in S9 Fig (media A and C) were analysed by LC/MS and the con-
centrations of selected amino acids and derivatives were calculated from their mean peak areas
with reference to standard curves (S10 and S11 Figs). Aspartate and alanine are examples of
‘non-essential’ amino acids present at the same initial concentrations in both media. As
expected, aspartate levels were greatly reduced in day 6 extracts in both media while alanine
was released and these trends were also observed in the day 3 extracts (S10 Fig). Also as
expected, the concentrations of essential amino acids in medium C, in which they were sup-
plied entirely by the 10% FCS, were 3 to 5-fold lower than in medium A. Despite the differences
in availability, however, similar amounts of phenylalanine and arginine were consumed in
both cultures A and C; representing a markedly higher percentage of the total initially available
in medium C. Similarly, the amount of tyrosine consumed in medium C was some 75% of that
in medium A. The situation for tryptophan, however, was different. The use over the first three
days was similar in media A and C but by day 6 it had been completely removed from the
medium in both cultures A and C; thus the level of tryptophan consumption was 5-fold higher
in medium A although growth was similar in both.
To analyse further the requirement of tryptophan for growth, L.major was grown in media
containing 10% or 2% FCS (S12 Fig). The reduction in FCS concentration resulted in only a
2-fold lower final titre in HOMEM-based media (P< 0.001) whilst there was further 2.6-fold
reduction in final titre (P< 0.001) when growth was compared in mHOMEM with 2% FCS
and HOMEM with 2% FCS; this reduced growth thus can be attributed to the lower concentra-
tions available of essential amino acids. A medium identical to HOMEM except for lacking
tryptophan with 2% FCS, which contained only approximately 3 μM tryptophan, supported
similar levels of growth as complete HOMEM with 2% FCS, which contained 50 μM trypto-
phan (S12 Fig). Tryptophan is essential for growth of L.major [26], but these results show that
the amount required (<3 μM) is very much less than the amount consumed (50 μM) when
available (S10 Fig).
Discussion
L. donovani, L.mexicana and L.major cause leishmaniasis with different clinical manifesta-
tions, visceral and cutaneous, and associated pathology [27]. Genomic and transcriptomic
analyses have not yet provided a full explanation for the distinct species-specific biology of the
three species [3,28]. Some distinct biological differences between the three species are, however,
known. For instance, the lipophosphoglycan on the surface of the promastigotes is species-spe-
cific and is thought to account for differences in their attachment to sand fly midgut and play a
role in the transmission to the mammalian host [29,30]. The species-specific gene A2 is impor-
tant for visceral infections in mice by L. donovani [31] and when introduced into L.major it
imparted some of the tissue tropic properties associated with L. donovani [32]. Nevertheless,
the major factors determining the different infection specificities of the three species had not
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been elucidated. We reasoned that knowledge of the metabolomes of the three species may
shed light on key biochemical differences between the species that could be instrumentmental
in determining the disease phenotypes in the mammal. Unfortunately it is not currently possi-
ble to obtain the disease-causing stage of the parasite, the amastigote, pure and in sufficient
numbers to allow comparative metabolomics analyses to be undertaken. Knowledge of the
extent to which amastigotes and promastigotes of Leishmania differ biochemically is very lim-
ited [13,33–36], some differences have been established although the published metabolomics
investigations using L.mexicana amastigotes that were grown in vitro suggest that the meta-
bolic differences between the two parasite developmental forms perhaps are relatively few
[13,37]. Thus we adopted a pragmatic approach in this study and compared in vitro grown pro-
mastigotes of the three species in the hope that this would reveal interesting biochemical differ-
ences that may be relevant to the amastigote stages too and so provide some insights into the
mechanisms underlying the biological specificitiesof the three species. We used equivalent pro-
mastigote forms, as far as it is possible to determine with currently available methodologies, to
minimise any variations due to growth phase.
As part of the study, we developed the methodology for analysing the metabolomes of the
cells. A full description of our optimisation of column types and mobile phase composition for
the detection of the maximum number of metabolites is published elsewhere (25). Our method
incorporated both reverse phase and HILIC columns and metabolite identity was confirmed by
the use of authentic standards and by interpretation of MS2 spectra. This enabled us to confirm
165 metabolites to MSI level 1 (S2 Table) that occurred in the cell extracts or spent media. In
addition, 604 metabolites were identified putatively on the basis of accurate mass and retention
time predicted by IDEOM. Thus the study has provided a foundation methodology that can be
applied extensively in future analyses of the metabolomes of pathogens in general.
This study has resulted in extensive information on the metabolites present in both the cells
themselves and the media after their growth. Clearly, snapshot data such as those obtained in
this study always have to be interpreted carefully and the recent demonstration that de novo
synthesis of serine, glycine and proline was repressed in the presence of exogenous amino acids
[38] provides a good example of the complex interplay that exists between culture conditions
and metabolism which may not mirror that which occurs in vivo. However, our experimental
approach was to compare the three different species in the same growth phase and under the
same conditions, with the expectation that differences observed would give a good indication
of innate genetic and physiological species-specificities. Indeed, the main purpose and outcome
of any global metabolomics analysis is to generate hypotheses that can be tested by detailed bio-
chemical analysis. The current study has revealed many interesting differences between the
metabolism of the three Leishmania species, particularly in the area of amino acid metabolism.
Amino acids are abundant in the gut of the sand fly in which promastigotes multiple naturally,
and some are thought to be used as energy sources [39]. They are also thought to be present in
large amounts within the parasitophorous vacuole within macrophages in which the parasite
resides in the human host [40]. Leishmania can synthesize some amino acids de novo, but they
are auxotrophic for many [41] and require salvaging these from their hosts. Our findings con-
firm that they are able to do this effectively and, indeed, in quantity for some amino acids (S6
Table). The findings concerning amino acid usage also prompt speculative hypotheses on how
the species differences, if they occur also with the amastigotes that are responsible for human
diseases, could explain the distinct disease phenotypes resulting from the infections of humans
with the parasites.
It is well established that one mechanism whereby some pathogens attenuate the mamma-
lian host’s immune response is through the depletion of amino acids central to immune mech-
anisms [42,43,44]. Our results which have revealed that promastigotes of the three Leishmania
Metabolomic Analyses of Leishmania Species
PLOS ONE | DOI:10.1371/journal.pone.0136891 September 14, 2015 19 / 29
species differ extensively in their use of some amino acids (Fig 2A and 2B) suggest that perhaps
such a survival mechanism has evolved for Leishmania. Moreover, if the species-specificities in
amino acid consumption found with promastigotes also occur with amastigotes they could
play an important part in determining where each parasite can survive and flourish.
Some of the most interesting findings are the very clear and distinct inter-specific differ-
ences in the consumption of tryptophan and arginine, two amino acids that have been shown
to be of particular importance in mammalian immune responses [42,43]. L.major consumed
all of the tryptophan from the medium whereas L. donovani consumed about half and L.mexi-
cana approximately two thirds (Figs 2 and 3, S6 Table). Tryptophan is an essential amino acid
in mammals and, importantly, plays key roles in the immune response, including that against
pathogens [42–46]. One anti-pathogen mechanism is for the host to deprive the pathogen of
tryptophan, apparently by stimulating the consumption of the amino acid by the host cells via
the kynurenine pathway. Such an immune mechanism depends upon the need of the pathogen
for tryptophan and its inability to synthesise it. One good example is the case ofMycobacterium
tuberculosis, and, interestingly, it was recently reported that the pathogen can overcome immu-
nity and so become persistent by activating genes enabling it to synthesise tryptophan de novo
[47]. Leishmania is considered auxotrophic for tryptophan and also lacks the genes for biosyn-
thesis [41,33], although our data indicates that L.major need relatively low concentrations for
survival. Clearly the amino acid is required for protein synthesis, although catabolism to
indole-3-lactate had also been reported [48]. Thus the wholescale utilisation of exogenous tryp-
tophan by L.major, unlike the other two species, raised three immediate questions. Firstly, do
amastigotes similarly avidly use this amino acid? If this is the case, then is this wholescale use
of tryptophan by L.major a means of countering the host cell’s immune response? Does the
parasite use it in some way beneficial to itself other than simply getting sufficient for its protein
needs? The different extent to which the three parasites consumed exogenous tryptophan also
suggested that perhaps they metabolised it in different ways and also that they may well have
different, at least quantitatively, mechanisms for attenuating the host’s immunity. The latter
point is consistent with many immunological studies over many years [46,49–52] and also
could help explain why the three species reside in different tissues and thus host cells in
mammals.
We investigated whether or not the three species catabolise tryptophan differently and our
results show that indole-3-lactate is by far the major end-product in each case and accounts for
effectively all of the tryptophan consumed from the medium. Just small amounts of indole-
3-acetate, indole-3-pyruvate and kynurenate were released. This pathway to indole-3-lactate is
likely to involve aminotransferase and hydroxyacid dehydrogenase enzymes and we detected
the former activity in cell extracts of all three species (Table 5). The specific activities, however,
did not correlate with the relative rate of consumption of tryptophan by the species, which may
therefore be determined either by the rate of uptake of the amino acid or the rate of its conver-
sion to the lactate. We were unable to detect the dehydrogenase activity in cell extracts as previ-
ously reported for L.mexicana [53]. Leishmania encodes a cytoplasmic malate dehydrogenase
(cMDH) with 50% similarity to the aromatic hydroxyacid dehydrogenase (AHADH) present
in Trypanosoma cruzi that reduces phenyl pyruvate and 4-hydroxyphenyl pyruvate [53]. How-
ever, although the T. cruzi AHADH is structurally related to cMDH it has no activity with oxa-
loacetate as a substrate whereas the L.major cMDH has a high specificity for oxaloacetate
indicating that it functions as a malate dehydrogenase [53,54]. The release of aromatic lactates
by the three species (Table 4, S8 Table) shows that that an AHADH activity must be present in
Leishmania, although it may require special conditions for function. AHADH activity catalys-
ing the formation of p-hydroxyphenyl-lactate from 4-hydroxyphenyl pyruvate, the product of
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tyrosine transamination, was recently detected in L. infantum cell extracts, although the activ-
ity was very low [55]. However the gene for the Leishmania AHADH is yet to be identified.
Trypophan degradation via the kyurenine pathway is an important component in the
immune response and there have been reports that L.majormodulates this, although with dif-
fering conclusions on the importance of the mechanism [33,41,44,]. Indoleamine 2,3 dioxygen-
ase (IDO) seems the key regulatory enzyme of the pathway and inhibition of this is perceived
to have potential in anticancer therapies [56,57]. A known inhibitor of IDO is 1-methyl-L-tryp-
tophan (1MLT) and this has been tested for an effect against experimental infections against
Leishmania [51,52,58], although without yielding consensus data. We looked for an effect of
the inhibitor against the parasite itself, with the hypothesis that it may interfere with trypto-
phan consumption by the parasite even though the parasite apparently lacks a IDO homologue.
However, we found that 1MLT has no growth inhibitory activity (IC50> 1 mM) and also that
adding 1MLT to growing cultures at 1 mM did not change metabolism at all as judged by the
intracellular and released metabolomes (data not shown).
The outstanding question is why the parasite carries out this catabolism of tryptophan. The
amount of tryptophan converted to indole-3-lactate by L.major promastigotes was more than
10-fold higher than the concentration the parasite required for growth (S10 and S12 Figs). The
pathway generates NAD+ and so could function as a means of helping to maintain redox
homeostasis, although it was reported that addition of exogenous tryptophan had no effect on
the intracellular NAD+ content [59]. We suggest that the avid utilisation, if also carried out by
the intracellular amastigote form, could be a means of depleting the host cell of tryptophan and
hence suppressing the T-cell response [51,52] and thus represent a parasite strategy for evading
the immune system. Differing use of tryptophan by the three species would be consistent with
them having differing matrices of responses for immune evasion and that perhaps they are
adapted for survival and growth in different host cells.
Although tryptophan utilisation showed the most extreme species-specificity on a percent-
age basis, other amino acids were consumed by the three species in very different amounts. A
notable example was arginine, with L.mexicana using 4-fold more than L. donovani, with L.
major being intermediate. Arginine is considered to be another key metabolite in the mamma-
lian immune response and has been implicated in a number of ways [43,60,61]. One route of
catabolism is to generate nitric oxide (_NO) via nitric oxide synthase (NOS)._NO is an important
component in the cytotoxic action of macrophages and it has been shown that activated mac-
rophages kill L.major via _NO production [62]. Stimulation of _NO production within macro-
phages has been shown to increase their level of cytotoxicity against canine visceral
leishmaniasis [63]. Arginine also affects a mitogen activated kinase (MAP kinase) signalling
pathway involved in the innate immune response to microbial pathogens [64,65]. Thus scav-
enging arginine and so depriving the host cell of this key amino acid could also be a mechanism
of immune evasion [60,61] and our data on arginine consumption (S6 Table), if it is reflective
of the consumption by amastigotes too, would be consistent with differing in importance of
this mechanism between species.
What is the fate of the consumed arginine? We investigated this by analysing possible catab-
olites. Initial observations suggested that citrulline was secreted in large amounts into the spent
medium and was also the most abundant intracellular metabolite in terms of rank order of
intensity. This lead us to measure _NO production by Leishmania, as NOS activity was reported
previously [66], but we were unable to detect any _NOmetabolites (< 25 μM nitrate) in the
spent media. On more detailed investigation it became clear that the metabolite thought to be
citrulline had a slightly different retention time from the authentic citrulline standard and its
MS2 spectrum (S1 Fig) was consistent with this metabolite being arginic acid. Citrulline itself
was present in only low amounts in the complete medium and spent media (S6 Table). Arginic
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acid, which is formed via deamination of arginine followed by reduction, is not a substrate for
NOS and indeed is considered an end product. We were unable to quantify in molar terms the
amount of arginic acid released, but the very high intensity of the peak suggests that it was con-
siderable and this is consistent with the amounts detected of the other arginine catabolites that
were quantified (Fig 4). Arginic acid was not found in uninfected media samples and was there-
fore not produced by chemical degradation. Thus a working hypothesis is that the parasites
consume arginine and convert it to arginic acid as a mechanism of reducing the immune
response of the host cell. Moreover, the relative intensities of the arginic acid released by the
promastigotes of the three species, if also true for amastigotes, would be consistent with this
mechanism being more important for L.major than for the other two species.
Glutamate was also consumed in large amounts, especially by L.major which almost
depleted the medium of all of the amino acid (S6 Table). Recent data for L.mexicana suggest
that glutamate incorporation is minimal under standard in vitro culture conditions; this study
showed that C13-U-glutamate was incorporated into the secreted metabolites CO2, succinate,
alanine, acetyl-CoA and glutamine, with highest levels released by logarithmic phase promasti-
gotes [13]. Our data show that proline also was released into the medium in quite large
amounts by L.mexicana whereas the other two species consumed large amounts of proline
from the medium (S6 Table). It has been reported that proline is used as an energy substrate by
L. donovani [67,68], consistent with there being high concentrations of the amino acid in the
insect vector; however its conversion to glutamate is worth consideration. The related trypano-
somatid Trypanosoma brucei when grown in proline-enriched medium produced greatly
increased levels of glutamate, glutathione and trypanothione [69], consistent with this parasite
converting proline to glutamate. Thus proline-glutamate interconversions seem a real possibil-
ity. Many of the metabolites of the intermediate pathways were detected in the current study,
with some interesting differences in intensity between species. The data together suggest that
there are distinct species variations in glutamate-proline metabolism.
Both serine and threonine were consumed in great amounts by all three species (S6 Table),
and although Leishmania has the genes required to make threonine from aspartate semialde-
hyde and convert it to serine [68], serine uptake is known to be essential for L.major [70]. Ala-
nine and glycine were secreted in large amounts (S6 Table, Fig 2B), with there being distinct
species-specificity; especially for glycine. Some glycine might be derived from the hydrolysis of
hippuric acid, which is completely depleted in the spent growth media (Fig 2A, Table 3). Ala-
nine is a known end-product of glucose metabolism [71] and its release is thought to be a
mechanism for countering osmotic stress [71]; it has also been reported that glycine may act
similarly [72].
Clear species differences were observed concerning the presence of transamination products
of valine, leucine and isoleucine in the spent media (S8 Table). The three species consumed
similar amounts of leucine, but released very different amounts of the transamination product
4-methyl-2-oxopentanoic acid—L.major 10-fold more than L.mexicana. Leishmania use leu-
cine for sterol biosynthesis; 4-methyl-2-oxopentanoic acid is generated in the cytoplasm, fur-
ther oxidised in the mitochondrion to form hydroxymethylglutaryl-CoA and then directly
incorporated into sterols without prior conversion to acetyl-CoA [33,73]. However, the extent
of this conversion appeared species-specific. By using 13C-labelled leucine it was shown that L.
mexicana and L.major produced 76–52% of their sterols from leucine whereas the comparative
figure for L.donovani was only 24% [73]. The relatively low level of 4-methyl-2-oxopentanoic
acid released by L.mexicana is consistent with the greater use of the keto acid for sterol produc-
tion, but such a relationship is not true for the other two species suggesting that leucine is prob-
ably deaminated for other purposes too.
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The finding of this study that several other deamination products of amino acids are
released by the three species, most notably the phenylalanine derivative 3-phenyllactate which
was released in large amounts by both L. donovani and L.major (S8 Table), suggests that there
is a common route for amino acid catabolism which most likely involves broad specificity ami-
notransferase and hydroxyacid dehydrogenase enzymes. Glutamate, a common product of
aminotransferase activity, can be metabolised by glutamate dehydrogenase to generate reduc-
ing equivalents and ammonia. The release of ammonia by promastigotes, especially by L.mexi-
cana, is consistent with a role for the broad specificity aminotransferases in redox balance as
previously suggested [53].
Overall our data show markedly different metabolic patterns for L. donovani, L.mexicana
and L.major (Tables 2 and 3, Fig 2) and reveal distinct differences in the uptake or release of a
variety of metabolites by the three species; the metabolism of the three species is far from iden-
tical. Most notably, they use considerably different amounts of some amino acids, especially
tryptophan and arginine, and catabolise these to end-products, indole-3-lactate and arginic
acid respectively, that are simply released. One limitation of this study is that the analysis was
carried out using promastigotes. Unfortunately it is currently not possible to undertake such a
comparative analysis with amastigotes, either isolated from animals or cultured axenically.
This restriction has also been noted in several other recent publications studies [10,11,12]. We
propose that if these differences determined for promastigotes also occur between amastigotes
of the three species then they could comprise mechanisms that facilitate the survival of the par-
asites in their mammalian hosts by modulating the immune responses that the host is able to
mount against them. The differing consumption of these amino acids may be central to the
specific pathologies that the parasites cause and the different host cells in which the parasites
reside and multiple. Thus the data that we have generated with promastigotes can be used to
formulate hypotheses concerning mechanisms that could mediate the differing biology of the
three species in their mammalian host, the challenge, however, is to show whether or not amas-
tigotes similarly differ. Nevertheless, the outcome of this study provides clear evidence on the
value of global metabolomic analyses in detecting species-specific metabolic features, and also
give a framework within which to conduct further studies exploring the host-parasite
interactions.
Supporting Information
S1 Fig. Fragmentation of arginic acid.
(TIF)
S2 Fig. Heatmap showing the 50 most abundant metabolites in L. donovani and compara-
tive levels in the other species. Key to intensities: red,>3 x 107; yellow,>3 x106; blue< 3
x105.
(DOCX)
S3 Fig. Heatmap of the 25 metabolites most abundant in L. donovani spent medium and
their levels in the spent media of the other two species and in the original growth medium.
Key to intensities: red,>3 x 107; yellow,>3 x106; blue< 3 x105.
(DOCX)
S4 Fig. Growth of Leishmania species in HOMEM with 10% FCS. Leishmania cultures were
initiated at 2.5 x 105 cells/ml in 10 ml HOMEM with 10% FCS on (culture day 1) and growth at
26°C was monitored by determining cells densities microscopically every 24 h for 7 days (cul-
ture day 8). The data are the means ± standard deviation (SD) from 3 replicate cultures.
(PPTX)
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S5 Fig. Standard curves of amino acids generated from LC-MS intensity values obtained
from varying concentration of the amino acids of interest.
(TIF)
S6 Fig. Standard curves of tryptophan and its potential catabolic products generated from
LC-MS intensity values obtained from varying the concentrations of the compounds of
interest.
(TIF)
S7 Fig. Heatmap showing metabolites accumulating in spent media for the three Leish-
mania species resulting from amino acid deamidation. Key to intensities: red,>3 x 107; yel-
low,>3 x106; blue< 3 x105.
(DOCX)
S8 Fig. The concentrations of selected amino acids determined by LC/MS.Medium A,
HOMEM with 10% FCS; medium C, mHOMEM (without essential amino acids) with 10%
FCS; 10% FCS in H2O; 10% dFCS in H20. The data are means ± SD (n = 3).
(PPTX)
S9 Fig. Growth of L.major with different concentrations of ‘essential’ amino acids. Cultures
of L.major were initiated at 2.5 x 105 cells/ml. Growth media: A, HOMEM with 10% FCS; B,
HOMEM with 10% dFCS; C, mHOMEM with 10% FCS; D, mHOMEM with 10% dFCS. The
figure shows cell titres in day 3 and day 6 cultures of L.major. Data are the means ± SD of 3
biological replicates.
(PPTX)
S10 Fig. Metabolomic analysis of spent media obtained when L.major was grown with dif-
ferent concentrations of ‘essential’ amino acids using medium A (HOMEM with 10% FCS)
or medium C (mHOMEM with 10% FCS). Cultures of L.major were initiated at 2.5 x 105
cells/ml and samples taken on days 3 and 6. The data are the amino acid concentrations in
spent media samples and in uninfected medium, used as a control. They are means ± SD of 3
biological replicates.
(PPTX)
S11 Fig. Calibration curves for amino acids and derivatives.
(PPTX)
S12 Fig. Comparison of growth of L.major in media with different concentrations of
amino acids. (a) Growth in media with 10% FCS. L.major promastigotes from a day 6 culture
were washed 2-times in PBS and cultures at 2.5 x 105 cells/ml in the following media supple-
mented with 10% FCS: medium A, HOMEM;—Trp, HOMEM without tryptophan;-Arg
medium, HOMEM without arginine; medium C, mHOMEM. Cell titres were determined on
days 3 and 6; data are means ± SD of 3 biological replicates. (b) Growth in the same media with
2% FCS.
(PPTX)
S1 Table. Standards solutions of metabolites used to aid metabolite identification.
(XLSX)
S2 Table. Metabolites of confirmed identity detected in the extract samples and/or spent
media. The colour coding is explained at the end of the table.
(XLSX)
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S3 Table. Formulae of HOMEM and HOMEM without amino acids and amino acid con-
centrations in HOMEM and mHOMEM (modified HOMEM without essential amino
acids).
(XLSX)
S4 Table. Metabolites identified in extracts of promastigotes of the three Leishmania spe-
cies. The colour coding is explained at the end of the table.
(XLSX)
S5 Table. Metabolites identified in the media from cultures of promastigotes of the three
Leishmania species. The colour coding is explained at the end of the table.
(XLSX)
S6 Table. Concentrations of amino acids and derivatives in the media, as analysed using
the standard curves shown in S5 Fig.
(XLSX)
S7 Table. Relative levels of arginine metabolites detected in the cell extracts and spent
media.
(XLSX)
S8 Table. Concentrations of catabolites of phenylalanine, tyrosine, leucine, isoleucine and
valine in the media, as analysed using standard curves.
(XLSX)
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